Medacta Group Statistics
Total Valuation
Medacta Group has a market cap or net worth of GBP 2.79 billion. The enterprise value is 2.99 billion.
| Market Cap | 2.79B |
| Enterprise Value | 2.99B |
Important Dates
The next estimated earnings date is Friday, March 13, 2026.
| Earnings Date | Mar 13, 2026 |
| Ex-Dividend Date | May 9, 2025 |
Share Statistics
| Current Share Class | 19.94M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.04% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 11.98% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 34.33 and the forward PE ratio is 32.60.
| PE Ratio | 34.33 |
| Forward PE | 32.60 |
| PS Ratio | 5.04 |
| PB Ratio | 7.67 |
| P/TBV Ratio | 8.81 |
| P/FCF Ratio | 76.69 |
| P/OCF Ratio | 23.57 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.88, with an EV/FCF ratio of 82.09.
| EV / Earnings | 36.74 |
| EV / Sales | 5.21 |
| EV / EBITDA | 19.88 |
| EV / EBIT | 31.20 |
| EV / FCF | 82.09 |
Financial Position
The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.60.
| Current Ratio | 2.39 |
| Quick Ratio | 0.82 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 1.50 |
| Debt / FCF | 6.00 |
| Interest Coverage | 7.42 |
Financial Efficiency
Return on equity (ROE) is 24.70% and return on invested capital (ROIC) is 14.20%.
| Return on Equity (ROE) | 24.70% |
| Return on Assets (ROA) | 8.48% |
| Return on Invested Capital (ROIC) | 14.20% |
| Return on Capital Employed (ROCE) | 15.98% |
| Weighted Average Cost of Capital (WACC) | 10.31% |
| Revenue Per Employee | 271,341 |
| Profits Per Employee | 39,871 |
| Employee Count | 2,041 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 0.85 |
Taxes
In the past 12 months, Medacta Group has paid 14.38 million in taxes.
| Income Tax | 14.38M |
| Effective Tax Rate | 15.02% |
Stock Price Statistics
The stock price has increased by +12.11% in the last 52 weeks. The beta is 1.18, so Medacta Group's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | +12.11% |
| 50-Day Moving Average | 159.19 |
| 200-Day Moving Average | 147.16 |
| Relative Strength Index (RSI) | 33.46 |
| Average Volume (20 Days) | 3,784 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medacta Group had revenue of GBP 553.81 million and earned 81.38 million in profits. Earnings per share was 4.08.
| Revenue | 553.81M |
| Gross Profit | 374.44M |
| Operating Income | 92.57M |
| Pretax Income | 95.76M |
| Net Income | 81.38M |
| EBITDA | 138.58M |
| EBIT | 92.57M |
| Earnings Per Share (EPS) | 4.08 |
Balance Sheet
The company has 28.49 million in cash and 218.44 million in debt, with a net cash position of -189.94 million.
| Cash & Cash Equivalents | 28.49M |
| Total Debt | 218.44M |
| Net Cash | -189.94M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 363.97M |
| Book Value Per Share | 18.25 |
| Working Capital | 220.82M |
Cash Flow
In the last 12 months, operating cash flow was 118.51 million and capital expenditures -82.09 million, giving a free cash flow of 36.42 million.
| Operating Cash Flow | 118.51M |
| Capital Expenditures | -82.09M |
| Free Cash Flow | 36.42M |
| FCF Per Share | n/a |
Margins
Gross margin is 67.61%, with operating and profit margins of 16.72% and 14.69%.
| Gross Margin | 67.61% |
| Operating Margin | 16.72% |
| Pretax Margin | 17.29% |
| Profit Margin | 14.69% |
| EBITDA Margin | 25.02% |
| EBIT Margin | 16.72% |
| FCF Margin | 6.58% |
Dividends & Yields
This stock pays an annual dividend of 0.63, which amounts to a dividend yield of 0.41%.
| Dividend Per Share | 0.63 |
| Dividend Yield | 0.41% |
| Dividend Growth (YoY) | 29.06% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 15.44% |
| Buyback Yield | 0.04% |
| Shareholder Yield | 0.44% |
| Earnings Yield | 2.91% |
| FCF Yield | 1.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medacta Group has an Altman Z-Score of 5.77 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.77 |
| Piotroski F-Score | 6 |